《皮膚病學(xué)與過敏學(xué)進展》是一本國際性、同行評審的皮膚病雜志。該雜志發(fā)表的報告描述了過敏學(xué)、皮膚生物學(xué)和皮膚疾病各個方面的原始研究。該期刊由PubMed、Embase和Mnisw（Ministerstwo Nauki I Szkolnictwa Wy_szego——科學(xué)和高等教育部）編制索引。原創(chuàng)文章和致編輯的信件是標準功能。審稿應(yīng)在與主編協(xié)商后提交。特別文章、會議報告和書評由編輯委員會邀請。除非病例報告提供了新的生物學(xué)見解，否則很少適合發(fā)表在期刊上。該期刊按照國際醫(yī)學(xué)期刊編輯委員會（ICMJE）和世界醫(yī)學(xué)編輯協(xié)會（WAME）的標準，采用確保原稿原創(chuàng)性的程序。因此，也有必要提供關(guān)于每一位作者對出版物的投入范圍的信息，其中包括研究概念的作者、假設(shè)、方法、研究方案等，以及每一位作者的隸屬關(guān)系。編輯部遵守科學(xué)出版物的最高標準，與作者的合作是建立在有關(guān)人員/機構(gòu)在出版物開發(fā)過程中實際投入的信息透明度的基礎(chǔ)上的。所有代筆和客座作者的案件都將承擔(dān)作為科學(xué)疏忽的象征的慣常處罰。

Advances in Dermatology and Allergology/Post?py Dermatologii i Alergologii is an international, peer-reviewed, dermatologic journal. The Journal publishes reports describing original research on all aspects of allergology, cutaneous biology and skin diseases. The Journal is indexed by PubMed, EMBASE, and MNiSW (Ministerstwo Nauki i Szkolnictwa Wy?szego – Ministry of Science and Higher Education).Original Articles and Letters to the Editor are standard features. Review articles should be submitted only after consultation with the Editor-in-Chief. Special articles, Conference reports and Book reviews are invited by the Editorial Board. Case reports, unless they provide new biologic insights, are rarely appropriate for the Journal.The journal applies procedures ensuring the originality of manuscripts in accordance with the criteria of the ICMJE (International Committee of Medical Journal Editors) and WAME (World Association of Medical Editors). Therefore, it is also necessary to provide information on the scope of input of each author to the publication, among others who is the author of the concept of the study, assumptions, methods, study protocol, and the like, as well as on the affiliation of each of the authors. The editorial office observes the highest standards of scientific publication and the cooperation with authors is based on the transparency of information on the actual input of persons/institutions in the development of the publication. All cases of ghostwriting and guest authorship will be liable for customary penalty as an indication of scientific negligence.